A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...

New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...

By Gift BritonFor the first time, infants younger than 28 days (neonates) can safely receive Dolutegravir (DTG), one of the most effective and widely used HIV drugs worldwide.Since the World Health ...

Modern HIV treatment offers remarkable outcomes. This guide explores essential first steps, treatment advances, support ...